Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Diagnosis and treatment of drug-induced hyperthermia.

Musselman ME, Saely S.

Am J Health Syst Pharm. 2013 Jan 1;70(1):34-42. doi: 10.2146/ajhp110543. Review.

PMID:
23261898
2.

Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.

Perry PJ, Wilborn CA.

Ann Clin Psychiatry. 2012 May;24(2):155-62. Review.

PMID:
22563571
3.

[Malignant hyperthermia and its differential diagnosis].

Hüttemann K, Nowe T, Köhrmann M, Anetseder M, Schellinger PD.

Fortschr Neurol Psychiatr. 2009 Apr;77(4):203-11. doi: 10.1055/s-0028-1109297. Epub 2009 Apr 3. Review. German.

PMID:
19347791
4.

Drug-induced hyperthermia.

Chan TC, Evans SD, Clark RF.

Crit Care Clin. 1997 Oct;13(4):785-808. Review.

PMID:
9330841
5.

Adverse drug reactions resulting in hyperthermia in the intensive care unit.

McAllen KJ, Schwartz DR.

Crit Care Med. 2010 Jun;38(6 Suppl):S244-52. doi: 10.1097/CCM.0b013e3181dda0d4. Review.

PMID:
20502177
6.

Drug-induced hyperthermia and muscle rigidity: a practical approach.

Hadad E, Weinbroum AA, Ben-Abraham R.

Eur J Emerg Med. 2003 Jun;10(2):149-54. Review.

PMID:
12789076
7.

Recognizing serotonin toxicity in the pediatric emergency department.

Kant S, Liebelt E.

Pediatr Emerg Care. 2012 Aug;28(8):817-21; quiz 822-4. doi: 10.1097/PEC.0b013e31826289d9. Review.

PMID:
22863827
8.

Management of drug-induced hyperthermia.

Halloran LL, Bernard DW.

Curr Opin Pediatr. 2004 Apr;16(2):211-5. Review.

PMID:
15021205
9.

The neuroleptic malignant and serotonin syndromes.

Carbone JR.

Emerg Med Clin North Am. 2000 May;18(2):317-25, x. Review.

PMID:
10767887
10.

Prevention, recognition, and management of serotonin syndrome.

Ables AZ, Nagubilli R.

Am Fam Physician. 2010 May 1;81(9):1139-42. Review.

11.

Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis.

Kaufman KR, Levitt MJ, Schiltz JF, Sunderram J.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):201-4.

PMID:
16923659
12.

The evaluation and management of patients with neuroleptic malignant syndrome.

Bhanushali MJ, Tuite PJ.

Neurol Clin. 2004 May;22(2):389-411. Review.

PMID:
15062519
13.

Neuroleptic malignant syndrome and its controversies.

Margetić B, Aukst-Margetić B.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):429-35. doi: 10.1002/pds.1937. Review.

PMID:
20306454
14.

Neuroleptic malignant syndrome.

Ingall TJ, Tennant C.

Med J Aust. 1986 Nov 3;145(9):454-5.

PMID:
3773831
15.

Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.

Sokoro AA, Zivot J, Ariano RE.

Ann Pharmacother. 2011 Sep;45(9):e50. doi: 10.1345/aph.1P787. Epub 2011 Aug 30.

PMID:
21878660
16.

Neuroleptic malignant syndrome.

Murray JB.

J Gen Psychol. 1987 Jan;114(1):39-46.

PMID:
2881974
17.

Neuroleptic malignant syndrome.

Keltner NL, McIntyre CW.

J Neurosurg Nurs. 1985 Dec;17(6):362-6.

PMID:
2868079
18.

[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].

Spiess-Kiefer C, Hippius H.

Fortschr Neurol Psychiatr. 1986 May;54(5):158-70. German.

PMID:
2426164
19.

[Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].

Schröder J, Linge C, Wähner A.

Fortschr Neurol Psychiatr. 1988 Mar;56(3):97-101. German.

PMID:
2896144
20.

[Neuroleptic malignant syndrome and related conditions].

Amore M, Montanari M.

Minerva Psichiatr. 1992 Oct-Dec;33(4):259-83. Review. Italian.

PMID:
1363674

Supplemental Content

Support Center